Navigation Links
New Therapy Enlists Immune System to Boost Cure Rate in a Childhood Cancer
Date:5/28/2009

apy group to live disease-free two years after treatment. "This 20 percent improvement in preventing relapse led to a greater cure rate -- the first substantial increase in cure rate for neuroblastoma for more than a decade," said Maris.

The researchers halted the trial earlier than expected after early results showed the benefits of immunotherapy. "This experimental immunotherapy is poised to become part of the new standard of care for children with the aggressive form of neuroblastoma," said Maris.

Maris added that the supply of the antibodies and cytokines used in the trial was limited, and that pediatric oncologists were seeking biotechnology companies to move the biological agents into commercial production to make the treatment readily available to children with neuroblastoma.

The Children's Hospital of Philadelphia has one of the nation's largest clinical and research programs in neuroblastoma. In 2008, Maris led a study that was the first to identify the gene location at which neuroblastoma originates. His laboratory continues to investigate how genes contribute to the disease, using that knowledge to devise new treatments.

Maris served as an oncologist for Alex Scott, the child with neuroblastoma who started a lemonade stand in 2000 to raise money for programs in childhood cancer. Now operated through the Scott family, the Alex's Lemonade Stand Foundation supports ongoing research by members of the Children's Oncology Group.

About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is a
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
6. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
7. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
8. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
9. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...all/--OptimerPharmaceuticals,Inc.(Nasdaq: OPTR )is...hCareConferenceatTheNewYorkPalaceinNewYorkCityonDe...tp://www.newscom.com/cgi-bin/prnh/20090413/LA97352...llbeaccessibleontheInvestorspageoftheCompany,swebs...tationwillbeavailableatthesamelocationfor30daysfol...
(Date:11/24/2009)...-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopha...izingnovelpainmanagementtherapies,todayannouncedth...ectiveNovember19,2009.Mr.Orwinisa20-yearsalesandma...beeninstrumentalinthelaunchofseveralimportantthera...President,BioOncologyBusinessUnitatGenentech,Inc.,...
(Date:11/23/2009)...wswire/--FebeDurango-Rueda,52,aColombiannational,p...todefraudtheExport-ImportBankoftheUnitedStates(Ex-...neyGeneraloftheCriminalDivisionLannyA.BreuerandAct...,OfficeoftheInspectorGeneral. ,, Durangopleaded...rtinWashingtontoaone-countcriminalinformationcharg...
Breaking Medicine Technology:NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Evolution Evidence Overturned 61598 1Evolution Evidence Overturned 61598 2Evolution Evidence Overturned 61598 3Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment 14893 1Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment 14893 2Hand washing Compliance Computer Auto Log on Log off and Patient Fall detection are Enabled by Real Time Location System 28RTLS 29 with Sub room Lo 14890 1Hand washing Compliance Computer Auto Log on Log off and Patient Fall detection are Enabled by Real Time Location System 28RTLS 29 with Sub room Lo 14890 2Hand washing Compliance Computer Auto Log on Log off and Patient Fall detection are Enabled by Real Time Location System 28RTLS 29 with Sub room Lo 14890 3Hand washing Compliance Computer Auto Log on Log off and Patient Fall detection are Enabled by Real Time Location System 28RTLS 29 with Sub room Lo 14890 4
... 8 AstraZeneca (NYSE: AZN ) and Targacept, Inc.... clinical trial of AZD3480 (TC-1734) conducted by ...nia (CDS), known as the HALO trial. , , AZD34...al significance on the primary endpoints, improvem...ntegNeuro computerized test battery. AZD3480 was g...
...Oncology,Company today reported updated results fr...inical trials of VELCADE based combinations for th...nts with previously untreated,multiple myeloma (MM...bserved,in one study comparing VELCADE and dexamet...ethasone (VAD), as well as in another study compar...
Other Medicine Technology:AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia 2AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia 4Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 2Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 3Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 4Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 5Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 7
(Date:11/24/2009)...ice regulatory consulting firm Emergo Group recent...distributors and industry service providers about ...n plans and their outlook for 2010. , ...09 -- Global medical device regulatory consulting... device and IVD manufacturers, distributors and in...
(Date:11/24/2009)...er, Home Care Delivered joins the American Diabete...eness for a disease that affects 24 million Americ...s) November 24, 2009 -- In conjunction with the Am...vered recognizes National Diabetes Awareness Mont... Nearly 24 million Americans have type 1 or type 2...
(Date:11/24/2009)... and Internet marketing specialists release report...e. , (PRWEB) November 24,...U.S. economy. Small business owners across the cou...sinesses afloat and reduce costs. Typically the fi...aining or marketing programs that aren’t per...
(Date:11/24/2009)...--LincolnCountyHeathcare(LCH)isasmallhealthsystemo...rementcommunities,employingmorethan1,200fullandpar...tgettingsuccessfulbackup,you,renotdoingyourjob,"sa...LCH.AsisthecasewithmanyhospitalsinMaine,budgetsare...designtoprotecthismissioncriticalsystems.Hedrewupa...
(Date:11/24/2009)...ire-FirstCall/--RegeneronPharmaceuticals,Inc.(Nasd...lPiperJaffrayHealthcareConferenceonTuesday,Decembe...rnTime.ThesessionmaybeaccessedthroughtheCompany,sw...age.Anarchivedversionofthepresentationwillbeavaila...ionalinformationaboutRegeneronandrecentnewsrelease...
Breaking Medicine News(10 mins):Health News:Medical Device Industry Positive About 2010 – Survey 2Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 2Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 3Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:Replay 4 Customer Takes Risk, Fights for Budget to Protect Information Systems 2
...SS Research announced the,findings of the latest w...y. The survey was completed in late June and found...Only coverage are definitely or very likely,to swi...kely" to switch, general satisfaction with their c...
...s, President, Campaign for Tobacco-Free,Kids, WAS...atthew L. Myers, President, Campaign for Tobacco-F...lauds Tyra Banks and her,television show "America,...on premiere of "America,s Next Top Model",featured...
...f children against Human Papilloma Virus (HPV) - t...nsmitted infection - will be discussed at the Nati...ngham today (1515hrs, Tuesday 2 October). , Profe...oretta Brabin, who is leading a pilot study into t...
... test,s ability to guide treatment , , TU...step to the standard test for prostate cancer migh...s. , Doctors now use what,s known as the Gleason t...earcher Dr. Abhijit A. Patel, a radiation oncologi...
... superior to conventional gamma imaging for bo... patients., NEWPORT NEWS, Va., Oct. 2 Recently p...ate that Breast-Specific Gamma Imaging,(BSGI) may ...eorge Washington University Medical Center, compar...
...he U.S. hospital marketplace,has become a battlegr...erapies on hospital formularies. Among the challen...th key physicians and the list of formulary,decisi...tal network administrators,and other decision make...
Other Medicine News:Health News:Tobacco-Free Kids Applauds Tyra Banks for Exposing the Ugly Truth About Smoking 2Health News:Study Supports Change to Prostate Cancer Biopsy 2Health News:Study Supports Change to Prostate Cancer Biopsy 3Health News:Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 2Health News:Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 3Health News:Equipping your Sales Force to Influence Hospital Formulary Decision-Makers 2
WarmTouch Model 5300 Warming Unit
...em from CSZ safely provides effective air warming ...atented design of our WarmAir® FilteredFlo®... which supplies gently moving, clean air that mini...inants to your patient or staff. All air is filter...
MAMMOMAT 3000 Nova Mammography System
4221/1000 Synoptophore
Medicine Products: